Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Immunization, Secondary | 4 | 2021 | 1649 | 0.30 | Why? |
| Hemagglutination Tests | 1 | 2021 | 124 | 0.21 | Why? |
| Antibody Formation | 3 | 2021 | 4038 | 0.19 | Why? |
| Antibodies, Monoclonal | 6 | 2021 | 8041 | 0.17 | Why? |
| Meningitis, Meningococcal | 1 | 2018 | 114 | 0.16 | Why? |
| T-Lymphocytes | 4 | 2021 | 6670 | 0.16 | Why? |
| Neisseria meningitidis | 1 | 2018 | 229 | 0.15 | Why? |
| Cytotoxicity, Immunologic | 1 | 2017 | 287 | 0.14 | Why? |
| Immunogenicity, Vaccine | 2 | 2020 | 4624 | 0.14 | Why? |
| Antibodies, Neutralizing | 7 | 2021 | 25288 | 0.13 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.13 | Why? |
| Antibodies, Viral | 8 | 2021 | 51949 | 0.13 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.12 | Why? |
| Single-Blind Method | 3 | 2021 | 1283 | 0.12 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.12 | Why? |
| Immunologic Memory | 2 | 2021 | 3362 | 0.11 | Why? |
| Adipose Tissue | 1 | 2017 | 612 | 0.11 | Why? |
| CD4-Positive T-Lymphocytes | 3 | 2021 | 4545 | 0.11 | Why? |
| Spike Glycoprotein, Coronavirus | 8 | 2021 | 37182 | 0.11 | Why? |
| Viral Vaccines | 3 | 2020 | 7560 | 0.10 | Why? |
| CD8-Positive T-Lymphocytes | 3 | 2021 | 5837 | 0.10 | Why? |
| CHO Cells | 2 | 2021 | 831 | 0.09 | Why? |
| Cricetulus | 2 | 2021 | 936 | 0.09 | Why? |
| Mass Vaccination | 1 | 2018 | 1101 | 0.09 | Why? |
| HEK293 Cells | 4 | 2021 | 8394 | 0.08 | Why? |
| Zika Virus | 1 | 2018 | 1924 | 0.07 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.07 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Zika Virus Infection | 1 | 2018 | 1920 | 0.07 | Why? |
| Vero Cells | 4 | 2021 | 14117 | 0.07 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.07 | Why? |
| Genetic Vectors | 2 | 2020 | 1600 | 0.06 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.06 | Why? |
| Immunity, Innate | 2 | 2018 | 6570 | 0.06 | Why? |
| Adenoviruses, Simian | 1 | 2020 | 52 | 0.05 | Why? |
| Agglutination Tests | 1 | 2021 | 124 | 0.05 | Why? |
| Interferon-gamma | 2 | 2021 | 2711 | 0.05 | Why? |
| Protein Binding | 3 | 2021 | 11430 | 0.05 | Why? |
| Binding Sites, Antibody | 1 | 2021 | 466 | 0.05 | Why? |
| Antigen-Antibody Complex | 1 | 2021 | 408 | 0.05 | Why? |
| Analgesics, Non-Narcotic | 1 | 2020 | 164 | 0.05 | Why? |
| Dose-Response Relationship, Immunologic | 1 | 2020 | 593 | 0.05 | Why? |
| Epitopes | 2 | 2021 | 4113 | 0.05 | Why? |
| Animals | 7 | 2021 | 78931 | 0.05 | Why? |
| Togo | 1 | 2018 | 95 | 0.05 | Why? |
| Carrier Proteins | 1 | 2021 | 513 | 0.04 | Why? |
| Protein Subunits | 1 | 2020 | 755 | 0.04 | Why? |
| Acetaminophen | 1 | 2020 | 326 | 0.04 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.04 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.04 | Why? |
| Protein Structure, Tertiary | 1 | 2021 | 1565 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2021 | 1517 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| United Kingdom | 3 | 2021 | 18046 | 0.04 | Why? |
| Immunoglobulin G | 4 | 2021 | 21571 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2020 | 813 | 0.04 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.04 | Why? |
| HIV Infections | 1 | 2021 | 11620 | 0.04 | Why? |
| Clinical Trials, Phase II as Topic | 1 | 2018 | 801 | 0.04 | Why? |
| Meningococcal Vaccines | 1 | 2018 | 225 | 0.04 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.04 | Why? |
| Antigens, Bacterial | 1 | 2018 | 330 | 0.04 | Why? |
| Immunization, Passive | 2 | 2021 | 10067 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.03 | Why? |
| Antibodies, Bacterial | 1 | 2018 | 510 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2021 | 2689 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2021 | 2739 | 0.03 | Why? |
| Humans | 18 | 2021 | 930598 | 0.03 | Why? |
| Cell Proliferation | 1 | 2021 | 1973 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Lymphocyte Activation | 1 | 2020 | 2742 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.02 | Why? |
| Mice | 2 | 2021 | 21357 | 0.02 | Why? |
| Male | 8 | 2021 | 367725 | 0.02 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2020 | 2262 | 0.02 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Age Factors | 2 | 2020 | 21039 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2020 | 3614 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.02 | Why? |
| Female | 7 | 2021 | 380317 | 0.02 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2021 | 3388 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2020 | 4849 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2021 | 6740 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2018 | 10017 | 0.01 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.01 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2018 | 27595 | 0.01 | Why? |
| Child | 1 | 2018 | 70012 | 0.01 | Why? |
Dold's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(114)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(466)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_